Learn More
Medchemexpress LLC SU5214 | 186611-04-1 | 251.28 | 100 MG

Supplier: Medchemexpress LLC HY21292100MG
SU5214 is a potent VEGFR2 inhibitor. It is extracted from patent US5834504A and is suitable for research use. It acts on Protein Tyrosine Kinase/RTK pathway.
- Potent VEGFR2 inhibitor
- Target for VEGFR
- Inhibits FLK-1 with an IC50 of 14.8 μM
- Inhibits EGFR with an IC50 of 36.7 μM
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.